Ayush organises yoga workshop for schoolteachers

Ayush organises yoga workshop for schoolteachers

Yashaswini S N & Charan CS, TNN Jun 26, 2012, 06.27AM IST

MYSORE: It is a widely acclaimed fact that yoga reduces anxiety and stress, resulting in good health, and that a yoga practitioner gets numerous health benefits. With this motto, the department of Ayush, in association with zilla panchayat, started yoga education camp for schoolteachers on Monday.Around 100 teachers from HD Kote are participating in the six day-yoga camp. Regional Telecom Training Centre has become a home for the participants for a week. They are being introduced to yoga, health and home treatment during a 12-hour session between 6am and 6pm. They are trained in different forms of yoga like Ashtangayoga, nature therapy, pranik healing, Ganapati exercise and the like.

Kerala may give tax concession on ayurveda medicines

THIRUVANANTHAPURAM: The state government is planning tax concession on ayurveda medicines along with other steps to boost the traditional system of medicine, said Mr Oommen Chandy, state Chief Minister.
Mr Oommen Chandy, said, “We are committed to set up authentic, quality products as well as classic, curative and promotional services such as wellness centres and ayurveda spas.We have now got the support of Sam Pitroda (adviser to the prime minister on public infrastructure, information and innovations) who is right now working on this. We are also looking at providing tax concession on ayurveda medicine.”
The state government had selected seven key areas in ayurveda for the wholesome development. VS Rajashekaran Pillai, former chief of Indira Gandhi National Open University, has stated that there is requirement to save and also boost the medicinal plants' plantation.

courtesy:indiamart.in

ASU opposes Ayush dept's new draft rule on label of ISM

MUMBAI: Industries of Ayurveda, Siddha and Unani (ASU) have firmly opposed the provisions which are enlisted in the draft rule 161 that is issued by the Department of Ayush. As per the provision, it requires all the ASU manufacturers to provide extra details on the labels of Indian Systems of Medicine (ISM) which is covered under the patent or proprietary of ASU therapies.
The entire idea of approving this provision is not pointless at all. The main reason is to lead redundant uncertainty within the industry. In the joint meeting held on June 13, the industry has expressed all its related concerns to the department.
“It is not possible for us to incorporate both scientific as well as official name on a single label along with all the ingredients which can range from 60 to 90 at times based on the products. Most importantly, to incorporate all of them in a single label we will be forced to reduce the font size which will further lead to violation of weight and measurement act.” said Chandrakanth Bhanushali, general secretary, Ayurvedic Drug Manufacturer’s Association.

courtesy:indiamart

Ayurveda Pharmacopoeia reconstituted as PCIM to take Ayush sector at next level

BENGALURU: Ayurveda Pharmacopoeia Commission is reconstituted as Pharmacopoeia Commission for Indian Medicine (PCIM) by the Union government. The major reason behind the reconstitution is to take Ayush sector to the next level of growth.
As per the Central Council of Research in Ayurvedic Sciences (CCRAS), provision under Rule 17.1 of the Rules and Regulations of Pharmacopoeia Commission for Indian Medicine, it will properly focus on the groundwork of official formularies and pharmacopoeias of single drugs and compound formulations as well.
Other main task of the Committee will be to lay down tests for identity, quality and purity as well. These tasks would ensure consistency of the physical properties and active components as well. Two experts namely, Prof V K Kapoor and Prof Karan Vashist, University Institute of Pharmaceutical Science, Chandigarh from the field of Analytical Chemistry, Pharmaceutical Chemistry, and Pharmaceutics are elected as non official members.

courtesy:indiamart

Dept of Ayush forms 5 sub-committees, KIMMA included to review lab practices to test ASU drugs Nandita Vijay, Bengaluru Monday, June 25, 2012, 08:00 Hrs  [IST]     Department of Ayush has constituted five sub-committees under the  Ayurveda Siddha Unani Drugs Technical Advisory Board (ASUDTAB). The Karnataka Indian Medicine Manufacturers Association (KIMMA) has been selected as the industry representative under the Sub Committee three to review lab practices to test Ayurveda Siddha and Unani (ASU) drugs. The first Sub Committee will examine Schedule ‘Z’ and other relevant notifications. The second Sub Committee is formed to evaluate the proposed Retail Sale Licence for ASU Drugs. The third Sub Committee would review the Model Laboratory Practices for testing of ASU drugs. The fourth Sub Committee is formed to amend First Schedule of Drugs & Cosmetics Act, 1940 for the list of Authoritative ASU Books. The fifth Sub Committee is to examine Shelf life of ASU Medicines. In a communiqué vide Government Order No. K.11025/1/2012-DCC (AYUSH) dated June 19, 2012, sub committees under ASUDTAB (Ayurveda Siddha Unani Drugs Technical Advisory Board) an Apex body vide sec 33-C of the Drugs and Cosmetics Act 1940 are now formed. The key objective of the sub-committee is to advise the Central and State Governments on technical matters arising out of Chapter IV A of the Drugs and Cosmetics Act, 1940. Industry is represented by Ayurveda Drug Manufacturers Association (ADMA) in Sub committees one and four, whereas Ayurvedic Medicine Manufacturers Organization of India (AMMOI) represents industry in Sub Committees two and five. According to JSD Pani, president, KIMMA, the move by the Union government to form sub committees is itself will give a fillip to the growth of the sector. The Ayush industry has now a path of progress. It is a step forward in making an effort to address the special issues of the industry where the industry is consulted through associations like ADMA and AMMOI. The regulatory decisions are also addressed after discussions with the stakeholders. “With the dire need for holistic care in the country where systems of Ayush and allopathy are being integrated into the healthcare space, we need to ensure that from research, manufacture to retail sales, the products will need to adhere to highest standards of quality. With KIMMA now being appointed to represent and review the Model Laboratory Practices for testing of ASU drugs, the focus will be to increase the scope for  quality of raw materials and process of research and development,” said Pani.